Established in 2021 within Saudi Arabia's Eastern Province, it has emerged as a prominent radiopharmaceutical manufacturer, drawing from the expertise of industry leaders like Ionex, Almoosa Specialist Hospital, and Abdullah Fouad Holding Company.
Oryx Isotopes is at the forefront of healthcare advancement, enabling healthcare providers with state-of-the-art radiopharmaceuticals for diagnostic and therapeutic purposes. With a solid foundation of loyal patrons and renowned specialists, their unwavering commitment to excellence shines bright.
Their comprehensive services encompass:
- Radiopharmacy and Cyclotron Operation
- Radiology and Nuclear Medicine Operation
- Radionuclide Therapy Procedures
- Medical Physics and Quality Assurance Services
From the local GCC market to a global reach, Oryx Isotopes stands as a collaborative partner in reshaping the landscape of medical capabilities.
